Compare Enovix Corporation (ENVX) vs Figs Inc (FIGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enovix Corporation vs Figs Inc — how do they compare? Enovix Corporation trades at $2.46 (market cap $549.72M), while Figs Inc trades at $15.78 (market cap $2.49B). The key difference: Figs Inc is far larger — about 4.5× Enovix Corporation's market cap, and Figs Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Figs Inc for 33 Days on average.
| ENVX | FIGS | |
|---|---|---|
Market Cap | $549.72M | $2.49B |
Volume | 6,635,687 | 5,964,311 |
Sector | Industrials | Consumer Cyclical |
52-Week High | $13.19 | $17.12 |
52-Week Low | $2.50 | $6.90 |
Typical Hold Time | 11 Days | 33 Days |
Enterprise Value | $611.42M | $2.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.46, down 3.53% on the day, with technical indicators signaling a bearish trend. The company reported a net loss of $156.74 million in 2025, with revenue of $31.82 million, and continues to burn cash, though it has beaten EPS estimates in recent quarters. Recent news includes CEO transition and expansion of battery manufacturing capacity.
Despite consistent EPS beats, ENVX faces significant financial challenges with negative margins and cash burn. Analyst consensus is bullish with a $10.75 price target, but high execution risk and leadership changes pose threats to near-term stability and long-term growth prospects.
FIGS stock trades at $15.78, up 12.23% with strong technical momentum and bullish moving averages. The company shows accelerating revenue growth from $556M in 2024 to $631M in 2025, with net income improving to $34M. Recent Q2 2026 earnings beat expectations by 64%, and international sales surged 67% according to Zacks Research on August 20, 2026. The stock faces valuation concerns with a P/E of 45.39, but analyst consensus targets $18.00 representing 14% upside potential.
Outlook remains positive with projected 2026 revenue of $710M and net income of $62M, though rich valuation requires continued execution. Key risks include competitive pressures and margin sustainability. With 60% analyst buy ratings and improving cash flow projections, FIGS offers growth exposure but demands careful risk management given premium multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →
